![Sofia Ioannidou](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sofia Ioannidou
Private Equity Investor chez
Andera Partners SCA
Profil
Sofia Ioannidou is a Partner at Andera Partners SCA since 2019, with employment at the firm starting in 2009.
Former positions include Director at Cellnovo Group SA, Director at TRiCares SAS, Independent Director at LogicBio Therapeutics, Inc. from 2017 to 2019, and Director at Avalyn Pharma, Inc. Education includes undergraduate and graduate degrees from the University of Oxford conferred in 2000, and a doctorate from University College London conferred in 2004.
Postes actifs de Sofia Ioannidou
| Sociétés | Poste | Début |
|---|---|---|
Andera Partners SCA
 Andera Partners SCA Investment ManagersFinance Andera Partners invests in companies located in France. The firm focuses on a broad range of sectors and industries. It provides debt financing through mezzanine, growth capital but also financing for later stage, LBO, MBO and buyout. The firm seeks for minority or majority stakes and also makes co-investments. | Private Equity Investor | 01/03/2013 |
Anciens postes connus de Sofia Ioannidou
| Sociétés | Poste | Fin |
|---|---|---|
| LOGICBIO THERAPEUTICS, INC. | Directeur/Membre du Conseil | 25/06/2019 |
| AVALYN PHARMA INC. | Directeur/Membre du Conseil | - |
TRiCares SAS
 TRiCares SAS Medical SpecialtiesHealth Technology Commercializes medical device | Directeur/Membre du Conseil | - |
| CELLNOVO | Directeur/Membre du Conseil | - |
Formation de Sofia Ioannidou
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
97
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Avalyn Pharma Inc.
 Avalyn Pharma Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops inhaled therapies to treat rare respiratory & interstitial lung diseases | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Andera Partners SCA
Andera Partners SCA Investment ManagersFinance Andera Partners invests in companies located in France. The firm focuses on a broad range of sectors and industries. It provides debt financing through mezzanine, growth capital but also financing for later stage, LBO, MBO and buyout. The firm seeks for minority or majority stakes and also makes co-investments. | Finance |
University College London
 University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cellnovo Group SA
 Cellnovo Group SA Medical SpecialtiesHealth Technology Manufactures medical device that manages diabetic control | Health Technology |
TRiCares SAS
TRiCares SAS Medical SpecialtiesHealth Technology Commercializes medical device | Health Technology |
LogicBio Therapeutics, Inc.
 LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines and therapies for bone metabolism, cardiology, neurology and rare diseases | Health Technology |
